Guru Ownership Trend
Guru Analysis for 4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11.49 M.
Top institutional holders include Renaissance Technologies (RenTech) and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $1.42 M net inflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for 4D Molecular Therapeutics, Inc. (FDMT)
Major holders include Renaissance Technologies (RenTech) ($8.17 M), Ken Fisher ($874,488), Cliff Asness ($668,737). According to the latest reported data, 3 tracked investment managers collectively hold approximately 730,605 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.42 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in FDMT during the most recent reporting period.
Yes, 1 managers opened new positions in FDMT, and 2 increased their existing holdings. The total reported buy value was $1.42 M.